Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282916811> ?p ?o ?g. }
- W4282916811 endingPage "1623" @default.
- W4282916811 startingPage "1612" @default.
- W4282916811 abstract "Type 2 diabetes (T2DM) is an established risk factor for developing Parkinson's disease (PD), but its effect on disease progression is not well understood.The aim of this study was to investigate the influence of T2DM on aspects of disease progression in PD.We analyzed data from the Tracking Parkinson's study to examine the effects of comorbid T2DM on PD progression and quality of life by comparing symptom severity scores assessing a range of motor and nonmotor symptoms.We identified 167 (8.7%) patients with PD and T2DM (PD + T2DM) and 1763 (91.3%) patients with PD without T2DM (PD). After controlling for confounders, patients with T2DM had more severe motor symptoms, as assessed by Movement Disorder Society Unified Parkinson's Disease Rating Scale, Part III (25.8 [0.9] vs. 22.5 [0.3] P = 0.002), and nonmotor symptoms, as assessed by Non-Motor Symptoms Scale total (38.4 [2.5] vs. 31.8 [0.7] P < 0.001), and were significantly more likely to report loss of independence (odds ratio, 2.08; 95% confidence interval [CI]: 1.34-3.25; P = 0.001) and depression (odds ratio, 1.62; CI: 1.10-2.39; P = 0.015). Furthermore, over time, patients with T2DM had significantly faster motor symptom progression (P = 0.012), developed worse mood symptoms (P = 0.041), and were more likely to develop substantial gait impairment (hazard ratio, 1.55; CI: 1.07-2.23; P = 0.020) and mild cognitive impairment (hazard ratio, 1.7; CI: 1.24-2.51; P = 0.002) compared with the PD group.In the largest study to date, T2DM is associated with faster disease progression in Parkinson's, highlighting an interaction between these two diseases. Because it is a potentially modifiable metabolic state, with multiple peripheral and central targets for intervention, it may represent a target for alleviating parkinsonian symptoms and slowing progression to disability and dementia. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society." @default.
- W4282916811 created "2022-06-16" @default.
- W4282916811 creator A5004111352 @default.
- W4282916811 creator A5007778657 @default.
- W4282916811 creator A5019530991 @default.
- W4282916811 creator A5040895889 @default.
- W4282916811 creator A5041647947 @default.
- W4282916811 creator A5043990676 @default.
- W4282916811 creator A5045141651 @default.
- W4282916811 creator A5046617667 @default.
- W4282916811 creator A5053419046 @default.
- W4282916811 creator A5059872338 @default.
- W4282916811 creator A5064943801 @default.
- W4282916811 creator A5066839058 @default.
- W4282916811 creator A5079394225 @default.
- W4282916811 creator A5087433800 @default.
- W4282916811 date "2022-06-14" @default.
- W4282916811 modified "2023-10-18" @default.
- W4282916811 title "The Impact of Type 2 Diabetes in Parkinson's Disease" @default.
- W4282916811 cites W1595575404 @default.
- W4282916811 cites W1803103211 @default.
- W4282916811 cites W1966864071 @default.
- W4282916811 cites W1969034413 @default.
- W4282916811 cites W1973092961 @default.
- W4282916811 cites W1982795519 @default.
- W4282916811 cites W1988821503 @default.
- W4282916811 cites W2014636870 @default.
- W4282916811 cites W2030360966 @default.
- W4282916811 cites W2042415736 @default.
- W4282916811 cites W2057042201 @default.
- W4282916811 cites W2058717577 @default.
- W4282916811 cites W2061125585 @default.
- W4282916811 cites W2063980028 @default.
- W4282916811 cites W2073848512 @default.
- W4282916811 cites W2079992029 @default.
- W4282916811 cites W2085653815 @default.
- W4282916811 cites W2086202837 @default.
- W4282916811 cites W2086679674 @default.
- W4282916811 cites W2089085990 @default.
- W4282916811 cites W2117875223 @default.
- W4282916811 cites W2122522567 @default.
- W4282916811 cites W2127951644 @default.
- W4282916811 cites W2138182947 @default.
- W4282916811 cites W2143425348 @default.
- W4282916811 cites W2150573372 @default.
- W4282916811 cites W2156013560 @default.
- W4282916811 cites W2255037565 @default.
- W4282916811 cites W2308274098 @default.
- W4282916811 cites W2474384121 @default.
- W4282916811 cites W2532190852 @default.
- W4282916811 cites W2618372037 @default.
- W4282916811 cites W2751112502 @default.
- W4282916811 cites W2754967293 @default.
- W4282916811 cites W2770346924 @default.
- W4282916811 cites W2776875854 @default.
- W4282916811 cites W2789827525 @default.
- W4282916811 cites W2795359717 @default.
- W4282916811 cites W2796381877 @default.
- W4282916811 cites W2807806732 @default.
- W4282916811 cites W2889076909 @default.
- W4282916811 cites W2897462382 @default.
- W4282916811 cites W2901737658 @default.
- W4282916811 cites W2904845744 @default.
- W4282916811 cites W2914529824 @default.
- W4282916811 cites W2968240930 @default.
- W4282916811 cites W2980434506 @default.
- W4282916811 cites W3034937256 @default.
- W4282916811 cites W3036895273 @default.
- W4282916811 cites W3108961512 @default.
- W4282916811 cites W3135159820 @default.
- W4282916811 cites W3137275994 @default.
- W4282916811 cites W3138465783 @default.
- W4282916811 cites W3149079883 @default.
- W4282916811 cites W3158349152 @default.
- W4282916811 cites W3199646305 @default.
- W4282916811 cites W3212048545 @default.
- W4282916811 cites W857664331 @default.
- W4282916811 doi "https://doi.org/10.1002/mds.29122" @default.
- W4282916811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35699244" @default.
- W4282916811 hasPublicationYear "2022" @default.
- W4282916811 type Work @default.
- W4282916811 citedByCount "16" @default.
- W4282916811 countsByYear W42829168112022 @default.
- W4282916811 countsByYear W42829168112023 @default.
- W4282916811 crossrefType "journal-article" @default.
- W4282916811 hasAuthorship W4282916811A5004111352 @default.
- W4282916811 hasAuthorship W4282916811A5007778657 @default.
- W4282916811 hasAuthorship W4282916811A5019530991 @default.
- W4282916811 hasAuthorship W4282916811A5040895889 @default.
- W4282916811 hasAuthorship W4282916811A5041647947 @default.
- W4282916811 hasAuthorship W4282916811A5043990676 @default.
- W4282916811 hasAuthorship W4282916811A5045141651 @default.
- W4282916811 hasAuthorship W4282916811A5046617667 @default.
- W4282916811 hasAuthorship W4282916811A5053419046 @default.
- W4282916811 hasAuthorship W4282916811A5059872338 @default.
- W4282916811 hasAuthorship W4282916811A5064943801 @default.
- W4282916811 hasAuthorship W4282916811A5066839058 @default.
- W4282916811 hasAuthorship W4282916811A5079394225 @default.